| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
REVIEW ARTICLE 2023 August 30
Intensity-Modulated Radiation Therapy for Uterine Cervical Cancer to Reduce Toxicity and Enhance Efficacy – an Option or a Must?: A Narrative Review
Radiotherapy (RT) is a fundamental modality in treatment of cervical cancer. With advancement of technology, conventional RT used for external beam radiotherapy (EBRT) for over half a century has been rapidly replaced with intensity-modulated radiation therapy (IMRT) especially ...
ORIGINAL ARTICLE 2023 August 2
Longitudinal Changes in Smoking Behaviors and Cancer-Related Mortality Risk in Middle-Aged Korean Women
Purpose This study investigated association between smoking habit change and cancer-related mortality risk in Korean women. Materials and Methods Study population were women aged ≥ 40 years who underwent two biennial cancer screenings during 2009-2012 and were followed up unti...
ORIGINAL ARTICLE 2023 September 7
Trends and Clinical Characteristics of Next-Generation Sequencing–Based Genetic Panel Tests: An Analysis of Korean Nationwide Claims Data
Purpose In the modern era of precision medicine, next-generation sequencing (NGS) is employed for a variety of clinical purposes. The aim of this study was to investigate the trends and clinical characteristics of NGS testing in South Korea. Materials and Methods This nationwid...
ORIGINAL ARTICLE 2023 July 20
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial
Purpose Precision oncology approach for recurrent and metastatic head and neck squamous cell carcinoma (HNSCC) is necessary due to its dismal prognosis. We performed a genomic profile-based umbrella trial of patients with platinum-refractory HNSCC (KCSG-TRIUMPH). Here, we presen...
Current Issue
Volume 56(1); Jan 2024
Volume 55(4); October 2023
Volume 55(3); July 2023
RSS feed

Accepted and E-pub version articles are published online before they appear in a regular issue of the journal. Accepted articles are PDF versions of manuscripts that have been peer reviewed and accepted for publication, but not yet copyedited or typeset, allowing readers the most rapid access to accepted papers. The accepted article remains on this page until the final proof version of the paper is posted in Epub Ahead-of Print page.
Accepted article is given its own Doi, so it can be citable as it has been linked to PubMed.

It may be cited as shown in the following example:
Park IH, Im SA, Jung KH, Sohn JH, Park YH, Lee KS, et al. Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01). Cancer Res Treat. 2018 Feb 14 [Epub]. https://doi.org/10.4143/crt.2017.562.

Original Articles
Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors
Yoon-Koo Kang, Min-Hee Ryu, Yong Sang Hong, Chang-Min Choi, Tae Won Kim, Baek-Yeol Ryoo, Jeong Eun Kim, John R. Weis, Rachel Kingsford, Cheol Hee Park, Seong Jang, Arlo McGinn, Theresa L. Werner, Sunil Sharma
Received August 29, 2023   Accepted January 17, 2024   Published online January 18, 2024
DOI: https://doi.org/10.4143/crt.2023.980    
[Accepted]
Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence After Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma
Jong Hoon Lee, Chung Un Lee, Jae Hoon Chung, Wan Song, Minyong Kang, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Hwan Sung
Received November 14, 2023   Accepted January 16, 2024   Published online January 17, 2024
DOI: https://doi.org/10.4143/crt.2023.1219    
[Accepted]
      
Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study
Junho Lee, Sung Hee Lim, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park
Received November 15, 2023   Accepted January 15, 2024   Published online January 16, 2024
DOI: https://doi.org/10.4143/crt.2023.1226    
[Accepted]
      
Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma
Sang Eun Yoon, Seung-Ho Shin, Dae Keun Nam, Junhun Cho, Won Seog Kim, Seok Jin Kim
Received July 23, 2023   Accepted January 15, 2024   Published online January 16, 2024
DOI: https://doi.org/10.4143/crt.2023.869    
[Accepted]
      
Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab After Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World Data
Jeong Yun Jang, Si Yeol Song, Young Seob Shin, Ha Un Kim, Eun Kyung Choi, Sang-We Kim, Jae Cheol Lee, Dae Ho Lee, Chang-Min Choi, Shinkyo Yoon, Su Ssan Kim
Received September 6, 2023   Accepted January 14, 2024   Published online January 16, 2024
DOI: https://doi.org/10.4143/crt.2023.1014    
[Accepted]
      
Predicted Cervical Cancer Prevention: Impact of National HPV Vaccination Program on Young Women in South Korea
Kyeongmin Kwak, Seung-sik Hwang
Received August 29, 2023   Accepted January 11, 2024   Published online January 15, 2024
DOI: https://doi.org/10.4143/crt.2023.981    
[Accepted]
      
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in NSCLC
Hanbaek Yi, Jeonghwan Youk, Yoojoo Lim, Hanseong Roh, Dongsoo Roh, Dongsoo Kyung, Hwang-Phill Kim, Duhee Bang, Bhumsuk Keam, Tae-Min Kim, Miso Kim, Dong-Wan Kim, Tae-You Kim
Received December 7, 2023   Accepted January 8, 2024   Published online January 8, 2024
DOI: https://doi.org/10.4143/crt.2023.1294    
[Accepted]
      Supplementary      
Bilateral Seminal Vesicle Invasion as a Strong Prognostic Indicator in T3b Prostate Cancer Patients Following Radical Prostatectomy: A Comprehensive, Multi-Center, Long-Term Follow-Up Study
Jungyo Suh, In Gab Jeong, Hwang Gyun Jeon, Chang Wook Jeong, Sangchul Lee, Seong Soo Jeon, Seok Soo Byun, Cheol Kwak, Hanjong Ahn
Received November 29, 2023   Accepted January 4, 2024   Published online January 5, 2024
DOI: https://doi.org/10.4143/crt.2023.1264    
[Accepted]
      
Combined High Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma: A Multi-Institutional Cohort Study
Jung Ho Im, Jeong Il Yu, Tae Hyun Kim, Tae Gyu Kim, Jun Won Kim, Jinsil Seong
Received July 28, 2023   Accepted December 31, 2023   Published online January 2, 2024
DOI: https://doi.org/10.4143/crt.2023.886    
[Accepted]
      
Association of Immune-Related Adverse Events and the Efficacy of Anti-PD-(L)1 Monotherapy in Non-Small Cell Lung Cancer: Adjusting for Immortal-Time Bias
Ying Yu, Ning Chen, Sizhe Yu, Wanji Shen, Wanchen Zhai, Hui Li, Yun Fan
Received October 11, 2023   Accepted December 30, 2023   Published online January 2, 2024
DOI: https://doi.org/10.4143/crt.2023.1118    
[Accepted]
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.6
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI